Sun Pharma Advanced Research Co (SPARC.NS) Stock Price
Sun Pharma Advanced Research Co Price
Revenue has compounded at 58.2% per year over the past 19 years to 18.79 B INR. Sun Pharma Advanced Research Co's net margin stands at 82.7%, up from -148.2% several years earlier.
Sun Pharma Advanced Research Co stock price
Sun Pharma Advanced Research Co business model & stock analysis
Frequently asked questions about Sun Pharma Advanced Research Co
10 analysts currently rate the Sun Pharma Advanced Research Co stock: 9 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Sun Pharma Advanced Research Co share trades at 1.82 EUR (196.79 INR).
The Sun Pharma Advanced Research Co share (SPARC.NS) is listed on 2 stock exchanges, including: NSE (Indien) (SPARC.NS).
The revenue of Sun Pharma Advanced Research Co is 18.79 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Sun Pharma Advanced Research Co is 15.53 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sun Pharma Advanced Research Co is currently 4.11. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sun Pharma Advanced Research Co stock.
The price-to-sales ratio (P/S) of Sun Pharma Advanced Research Co is currently 3.40. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sun Pharma Advanced Research Co stock.
The Eulerpool Quality Score for Sun Pharma Advanced Research Co is 6/10.
The ISIN of Sun Pharma Advanced Research Co is INE232I01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sun Pharma Advanced Research Co is SPARC.NS. The ticker symbol is used to trade Sun Pharma Advanced Research Co shares on the stock exchange.
Sun Pharma Advanced Research Co stock
Sun Pharma Advanced Research Co Peer Group
Sun Pharma Advanced Research Co Ticker
Sun Pharma Advanced Research Co FIGI
All fundamentals and in-depth analysis of Sun Pharma Advanced Research Co
Our stock analysis for Sun Pharma Advanced Research Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sun Pharma Advanced Research Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.